Loading...
Loading...
Teva Pharmaceutical Industries Ltd
TEVA announced today that it
had launched a generic version of Viagra® (sildenafil) immediately on
patent expiry in Germany, the United Kingdom, Italy, the Netherlands,
Switzerland, Ireland, Austria, Belgium and Denmark. The company had
already launched the product in Spain, Canada and certain other
countries.
Dipankar Bhattacharjee, President and CEO Europe Generics, welcomed the
launch: “Teva has a proud track record of bringing high-quality generics
to the market on day one of patent expiry, and we have been able to
launch sildenafil immediately on patent expiry in all the major markets
of Europe. The launch today of sildenafil will bring choice to the
pharmacy to help them serve the patient, and
See full press release© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in